THERAVANCE INC's ticker is and the CUSIP is 88338TAB0. A total of 28 filers reported holding THERAVANCE INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,691,000 | +0.2% | 20,000 | 0.0% | 0.01% | -14.3% |
| Q3 2016 | $1,687,000 | +4.5% | 20,000 | 0.0% | 0.01% | 0.0% |
| Q2 2016 | $1,614,000 | +3.3% | 20,000 | 0.0% | 0.01% | 0.0% |
| Q1 2016 | $1,563,000 | +5.4% | 20,000 | 0.0% | 0.01% | -12.5% |
| Q4 2015 | $1,483,000 | +11.7% | 20,000 | 0.0% | 0.01% | +14.3% |
| Q3 2015 | $1,328,000 | -29.4% | 20,000 | 0.0% | 0.01% | -12.5% |
| Q2 2015 | $1,880,000 | +7.4% | 20,000 | 0.0% | 0.01% | +14.3% |
| Q1 2015 | $1,750,000 | – | 20,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $1 | 0.00% |